Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Oxf Med Case Reports ; 2019(12): 498-501, 2019 Dec.
Article in English | MEDLINE | ID: mdl-31908820

ABSTRACT

We present a rare case detailing the investigations and subsequent treatment of a lady who presented with a reno-duodenal fistula and perinephric abscess as a complication of staghorn calculus and recurrent upper urinary tract infections. Treatment involved antibiotics, nephrostomy, endoscopic closure of the fistula tract with clips, radiological drain insertion and, ultimately, nephrectomy with primary omental patch closure of the duodenal defect. We discuss the incidence of fistula tract formation as a complication of staghorn calculi, as well as investigations and management strategies employed in the literature to treat such complications, which span from conservative treatment to nephrectomy and closure of the intestinal defect. We illustrate the post-operative complications such patients are prone to and discuss these in context of the case. Whilst such cases are rare clinicians should be vigilant for complications associated with chronic inflammatory processes occurring in the urinary tract and investigate accordingly.

2.
BMJ Case Rep ; 20152015 Feb 18.
Article in English | MEDLINE | ID: mdl-25694639

ABSTRACT

A 43 -year-old man was treated with pazopanib for metastatic renal cell carcinoma (RCC) with imaging studies suggesting a partial response to treatment. However, the patient presented numerous times with severe testicular pain and gradually increasing priapism. He underwent an inguinal orchidectomy for symptom control. Histopathology confirmed invasion of the cord and tunica vaginalis with metastatic RCC. Further CT of the abdomen and pelvis suggested non-progression of the disease. The patient continued to develop priapism for several weeks before imaging studies confirmed disease progression; a month later the patient died. Genital involvement in metastatic RCC is unusual but should alert clinicians to the possibility of disease progression.


Subject(s)
Acute Pain/etiology , Carcinoma, Renal Cell/pathology , Genital Neoplasms, Male/pathology , Kidney Neoplasms/pathology , Neoplasms, Second Primary/pathology , Priapism/etiology , Adult , Diagnosis, Differential , Disease Progression , Fatal Outcome , Genital Neoplasms, Male/complications , Humans , Male , Neoplasms, Second Primary/complications , Orchiectomy , Scrotum/pathology , Scrotum/surgery
3.
BJU Int ; 112(7): 885-97, 2013 Nov.
Article in English | MEDLINE | ID: mdl-24000900

ABSTRACT

• To review the published data on predisposing risk factors for cancer treatment-induced haemorrhagic cystitis (HC) and the evidence for the different preventive and therapeutic measures that have been used in order to help clinicians optimally define and manage this potentially serious condition. • Despite recognition that HC can be a significant complication of cancer treatment, there is currently a lack of UK-led guidelines available on how it should optimally be defined and managed. • A systematic literature review was undertaken to evaluate the evidence for preventative measures and treatment options in the management of cancer treatment-induced HC. • There is a wide range of reported incidence due to several factors including variability in study design and quality, the type of causal agent, the grading of bleeding, and discrepancies in definition criteria. • The most frequently reported causal factors are radiotherapy to the pelvic area, where HC has been reported in up to 20% of patients, and treatment with cyclophosphamide and bacillus Calmette-Guérin, where the incidence has been reported as up to 30%. • Mesna (2-mercaptoethane sodium sulphonate), hyperhydration and bladder irrigation have been the most frequently used prophylactic measures to prevent treatment-related cystitis, but are not always effective. • Cranberry juice is widely cited as a preventative measure and sodium pentosanpolysulphate as a treatment, although the evidence for both is very limited. • The best evidence exists for intravesical hyaluronic acid as an effective preventative and active treatment, and for hyperbaric oxygen as an equally effective treatment option. • The lack of robust data and variability in treatment strategies used highlights the need for further research, as well as best practice guidance and consensus on the management of HC.


Subject(s)
Antineoplastic Agents/adverse effects , Cystitis/etiology , Cystitis/therapy , Hemorrhage/etiology , Hemorrhage/therapy , Neoplasms/drug therapy , Neoplasms/radiotherapy , Cystitis/chemically induced , Hemorrhage/chemically induced , Humans , Incidence , Radiotherapy/adverse effects
4.
Urol Int ; 89(1): 83-8, 2012.
Article in English | MEDLINE | ID: mdl-22614181

ABSTRACT

OBJECTIVE: To describe for surgeons contemplating performing cytoreductive nephrectomy (CRN) on patients after neoadjuvant sunitinib compared to a benchmark of open radical nephrectomy, describing technical difficulties, safety and feasibility. PATIENTS AND METHODS: We compared measurable surgical parameters and perioperative complications in 22 patients with metastatic renal cell carcinoma (mRCC) undergoing CRN after neoadjuvant sunitinib, with 28 patients who underwent open radical nephrectomy for non-metastatic disease (nmRCC). RESULTS: Median blood loss (320 vs. 775 ml), median operative time (128 vs. 195 min) and median length of stay (5 vs. 7 days) were greater in the mRCC group. Surgery after sunitinib was technically challenging due to fibrosis, loss of the tissue planes that usually facilitate radical nephrectomy and abnormal blood vessel formation. Side effects of sunitinib resulted in predictable complications. CONCLUSION: CRN after treatment with sunitinib is safe and feasible in our hands, although the surgery is more time-consuming and technically demanding. A multidisciplinary approach is mandatory.


Subject(s)
Antineoplastic Agents/therapeutic use , Carcinoma, Renal Cell/drug therapy , Carcinoma, Renal Cell/surgery , Indoles/therapeutic use , Kidney Neoplasms/drug therapy , Kidney Neoplasms/surgery , Nephrectomy , Pyrroles/therapeutic use , Adult , Aged , Aged, 80 and over , Antineoplastic Agents/adverse effects , Biopsy , Blood Loss, Surgical , Carcinoma, Renal Cell/secondary , Female , Humans , Indoles/adverse effects , Kidney Neoplasms/pathology , Length of Stay , London , Male , Middle Aged , Molecular Targeted Therapy , Neoadjuvant Therapy , Neoplasm Staging , Nephrectomy/adverse effects , Postoperative Complications/etiology , Postoperative Complications/therapy , Pyrroles/adverse effects , Retrospective Studies , Risk Assessment , Risk Factors , Sunitinib , Time Factors , Tomography, X-Ray Computed , Treatment Outcome
5.
Eur J Emerg Med ; 14(1): 53-5, 2007 Feb.
Article in English | MEDLINE | ID: mdl-17198330

ABSTRACT

Genital foreign bodies constitute a diverse but surprisingly common means of presentation to emergency departments. Although the presentation usually means the initial diagnosis is easily made, we present a case here that stresses the importance of attention to history, clinical examination and radiological investigation. A 44-year-old gentleman presented with a history of pain and discharge from a self-inflicted scrotal wound. Further questioning revealed a history of genital foreign bodies, but the full extent of his condition was not apparent until plain pelvic radiographs were obtained. The initial management of genital foreign bodies follows basic surgical principles. Constricting bands must be removed, devitalized tissues debrided and the surgical field extensively irrigated. Underlying psychiatric illness may be present and a high index of suspicion is required in the initial assessment of such patients. A plain pelvic radiograph is recommended to fully identify all foreign bodies present.


Subject(s)
Penis , Scrotum/injuries , Adult , Foreign Bodies/diagnostic imaging , Foreign Bodies/surgery , Foreign Bodies/therapy , Humans , Male , Penis/diagnostic imaging , Radiography , Scrotum/diagnostic imaging
6.
Ann R Coll Surg Engl ; 85(2): 123-5, 2003 Mar.
Article in English | MEDLINE | ID: mdl-12648346

ABSTRACT

Drug-resistant nosocomial infections are an increasing problem. This issue has received considerable media coverage. To our knowledge there have been no studies investigating patient awareness and perceptions of nosocomial infections. A total of 113 surgical out-patients completed a questionnaire stating whether they had heard of either superbugs or MRSA. A series of questions were asked about the source of any information; methods of transmission and prevention; the consequences of infection and their emotional response if they were to acquire MRSA. Fifty patients (44%) had heard of superbugs or MRSA mainly via the media (58%) or from hospital staff (44%). The majority would feel either angry or afraid if they acquired MRSA in hospital, but there was good awareness of both methods of infection control and the consequences of infection. From our study, we conclude that the media is at least as important as health professionals in providing information. Concerns regarding nosocomial infection may need to be addressed prior to admission.


Subject(s)
Cross Infection/drug therapy , Methicillin Resistance , Patients/psychology , Staphylococcal Infections/drug therapy , Adult , Aged , Aged, 80 and over , Anger , Awareness , Cross Infection/psychology , Fear , Female , Humans , Male , Middle Aged , Perception , Staphylococcal Infections/psychology , Surveys and Questionnaires
SELECTION OF CITATIONS
SEARCH DETAIL
...